BCAX affiliate files Rule 144 for 28,000 shares

BCAX affiliate submitted a Rule 144 notice reporting proposed and recent sales of Common Stock.

Rhea-AI Filing Summary

BCAX affiliate submitted a Rule 144 notice reporting proposed and recent sales of Common Stock. The filing lists 28,000 shares and an aggregate dollar figure of $847,000.00 tied to the securities information. It also records two past sales of 9,200 shares each on 04/21/2026 and 05/21/2026 for $211,613.80 and $187,883.32, respectively.

The filing shows planned transfers linked to option exercises, including an entry of 12,500 shares associated with an exercise dated 07/08/2026 and 15,500 shares tied to an NQ exercise dated 05/08/2024. The record lists the broker as UBS Financial Services, Inc. and identifies NASDAQ as the market.

Insights

Securities Compliance Officer

Rule 144 notice lists proposed resale and recent affiliated sales without pricing mechanics.

The filing documents a proposed resale quantity of 28,000 shares and an aggregate dollar figure of $847,000.00 in the securities information line. It also records two completed sales of 9,200 shares on 04/21/2026 and 05/21/2026 with the exact proceeds shown.

These entries are procedural disclosures under Rule 144. Timing and method details for the proposed sales are limited to dates and exercise references; cash‑flow treatment and specific distribution methods are not stated in the excerpt. Subsequent filings or broker confirmations would clarify execution details.

Key Figures

Proposed shares listed: 28,000 shares Aggregate dollar figure: $847,000.00 Past sale — 04/21/2026: 9,200 shares +3 more

6 metrics

Proposed shares listed 28,000 shares Securities Information line

Aggregate dollar figure $847,000.00 Securities Information line

Past sale — 04/21/2026 9,200 shares Sale on 04/21/2026 for $211,613.80

Past sale — 05/21/2026 9,200 shares Sale on 05/21/2026 for $187,883.32

Exercise entry dated 07/08/2026 12,500 shares Listed as 'Exercise of stock options' dated 07/08/2026

NQ Exercise dated 05/08/2024 15,500 shares Listed as 'NQ Exercise' dated 05/08/2024

Key Terms

Rule 144, NQ Exercise, Exercise of stock options, Issuer

4 terms

Rule 144 regulatory

"Rule 144 notice context and header identifying the filing as '144: Filer Information'"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

NQ Exercise financial

"Line reading '05/08/2024 | NQ Exercise | Issuer' referencing a 15,500 share entry"

Exercise of stock options financial

"Entry '07/08/2026 | Exercise of stock options | Issuer' tied to 12,500 shares"

Issuer regulatory

"Repeated label in securities-to-be-sold rows indicating the party associated with the transactions"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BCAX's Form 144 report?

It reports proposed and recent sales of Common Stock by an affiliate. The filing lists 28,000 shares and an aggregate figure of $847,000.00, plus two prior sales of 9,200 shares each on 04/21/2026 and 05/21/2026.

Who is the broker listed on the BCAX Rule 144 notice?

The broker is listed as UBS Financial Services, Inc. at 11 Madison Ave, New York. The filing also identifies NASDAQ as the market associated with the securities information line.

What recent sales are disclosed in BCAX's filing?

Two completed sales are disclosed: 9,200 shares sold on 04/21/2026 for $211,613.80 and 9,200 shares sold on 05/21/2026 for $187,883.32. These amounts are shown verbatim in the excerpt.

Does the filing show shares tied to option exercises?

Yes. The excerpt lists an entry of 12,500 shares linked to an exercise dated 07/08/2026 and an entry of 15,500 shares tied to a nonqualified exercise dated 05/08/2024.

Are proceeds or distribution methods for the proposed sale detailed?

The excerpt shows an aggregate dollar figure of $847,000.00 in the securities information line but does not specify sale mechanics or which party will receive proceeds; the filing text provides dates and exercise labels without detailed distribution terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/08/2026 - 04:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034668
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Hyep Ivan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	28000	847000.00	65703866	07/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/08/2026	Exercise of stock options	Issuer			12500	07/08/2026	Cash
Common	05/08/2024	NQ Exercise	Issuer			15500	05/08/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	04/21/2026	9200	211613.80
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	05/21/2026	9200	187883.32

144: Remarks and Signature

Remarks
Date of Notice	07/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ivan Hyep
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)